The drug registration process in Korea typically takes around 12 to 24 months. This includes the data review, and regulatory approval by the Ministry of Food and Drug Safety (MFDS). The timeline can vary depending on the drug’s complexity whether a local clinical trial is needed in Korea. and the completeness of the submitted data.
